HomeACADEMIA
ACADEMIA

PCSK9 Inhibitors More Effective than Statins at Lowering LDL-C: New Atherosclerosis Prevention Guidelines
(Jan.31.2017)

The Japan Atherosclerosis Society (JAS) announced an outline of its 2017 guidelines for the prevention of atherosclerotic cardiovascular diseases on January 29. The society points out that the safety of PCSK9 inhibitors in long-term administration has not been confirmed, but it says that they are more effective than statins at lowering LDL cholesterol (LDL-C) ...
(LOG IN FOR FULL STORY)

News Calendar